Low-dose fixed combination of bisoprolol/hydrochlorothiazide as first line for hypertension: A review of the rationale and clinical evidence

Angiology

Volumn 60, Issue 5, 2009, Pages 601-607

  Papadopoulos, Dimitris P ^a   Papademetriou, Vassilios ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

Bisoprolol HCTZ; Combination; Hypertension

Indexed keywords

AMLODIPINE; BISOPROLOL; BISOPROLOL FUMARATE PLUS HYDROCHLOROTHIAZIDE; ENALAPRIL; HYDROCHLOROTHIAZIDE; HYDROCHLOROTHIAZIDE PLUS METOPROLOL; PLACEBO;

ANTIHYPERTENSIVE THERAPY; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DIZZINESS; DOSE RESPONSE; DRUG ABSORPTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG POTENTIATION; ESSENTIAL HYPERTENSION; HUMAN; HYPERTENSION; HYPOKALEMIA; HYPOURICEMIA; LOW DRUG DOSE; MONOTHERAPY; REVIEW; TREATMENT RESPONSE;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; ANTIHYPERTENSIVE AGENTS; BISOPROLOL; BLOOD PRESSURE; DIURETICS; DRUG COMBINATIONS; EVIDENCE-BASED MEDICINE; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; PRACTICE GUIDELINES AS TOPIC; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 70350475890     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/0003319708324926     Document Type: Review

References (28)

1. Papadopoulos DP, Papademetriou V. Resistant hypertension: diagnosis and management. J Cardiovasc Pharmacol Ther. 2006 ; 11: 113-118.
2. Fields LE, Burt VL, Cutler JA, Hughes J., Roccella EJ, Sorlie P. The burden of adult hypertension in the United States 1999 to 2000: a rising tide. Hypertension. 2004 ; 44: 398-404.
3. Neutel JM The use of combination drug therapy in the treatment of hypertension. Prog Cardiovasc Nurs. 2002 ; 17: 81-88.
4. Prisant LM Fixed low-dose combination in first-line treatment of hypertension. J Hypertens. 2002 ; 20: S11 - S19.
5. Rosenberg J., Gustafsson F. Bisoprolol for congestive heart failure. Expert Opin Pharmacother. 2008 ; 9: 293-300.
6. Leopold G., Pabst J., Ungethum W., Buhring KU Basic pharmacokinetics of bisoprolol, a new highly beta 1-selective adrenoceptor antagonist. J Clin Pharmacol. 1986 ; 26: 616-621. (Pubitemid 17183525)
7. McGavin JK, Keating GM Bisoprolol: a review of its use in chronic heart failure. Drugs. 2002 ; 62: 2677-2696.
8. Kirch W., Rose I., Demers HG, et al. Pharmacokinetics of bisoprolol during repeated oral administration to healthy volunteers and patients with kidney or liver disease. Clin Pharmacokinet. 1987 ; 13: 110-117.
9. Lancaster SG, Sorkin EM Bisoprolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and angina pectoris. Drugs. 1988 ; 36: 256-285.
10. Prichard BN Bisoprolol: a new beta-adrenoceptor blocking drug. Eur Heart J. 1987 ; 8 (suppl M). 121-129.
11. Haeusler G., Schliep HJ, Schelling P., et al. High beta 1-selectivity and favourable pharmacokinetics as the outstanding properties of bisoprolol. J Cardiovasc Pharmacol. 1986 ; 8 (suppl 11). S2 - S15.
12. Zachariah PK, Messerli FH, Mroczek W. Low-dose bisoprolol/ hydrochlorothiazide: an option in first-line, antihypertensive treatment. Clin Ther. 1993 ; 15: 779-787.
13. Mougenot N., Mediani O., Lechat P. Bisoprolol and hydrochlorothiazide effects on cardiovascular remodeling in spontaneously hypertensive rats. Pharmacol Res. 2005 ; 51: 359-365.
14. Lewin AJ, Lueg MC, Targum S., Cardenas P. A clinical trial evaluating the 24-hour effects of bisoprolol/hydrochlorothiazide 5 mg/6.25 mg combination in patients with mild to moderate hypertension. Clin Cardiol. 1993 ; 16: 732-736.
15. Luna RL, Oigman W., Ramirez JA, et al. Efficacy and tolerance of the bisoprolol/hydrochlorothiazide combination in arterial hypertension. Arq Bras Cardiol. 1998 ; 71: 601-608. (Pubitemid 29010904)
16. Frishman WH, Burris JF, Mroczek WJ, et al. First-line therapy option with low-dose bisoprolol fumarate and low-dose hydrochlorothiazide in patients with stage I and stage II systemic hypertension. J Clin Pharmacol. 1995 ; 35: 182-188.
17. Frishman WH, Bryzinski BS, Coulson LR, et al. A multifactorial trial design to assess combination therapy in hypertension. Treatment with bisoprolol and hydrochlorothiazide. Arch Intern Med. 1994 ; 154: 1461-1468.
18. Prisant LM, Weir MR, Papademetriou V., et al. Low-dose drug combination therapy: an alternative first-line approach to hypertension treatment. Am. Heart J. 1995 ; 130: 359-366.
19. Papademetriou V., Prisant LM, Neutel JM, Weir MR Efficacy of low-dose combination of bisoprolol/hydrochlorothiazide compared with amlodipine and enalapril in men and women with essential hypertension. Am J Cardiol. 1998 ; 81: 1363-1365.
20. Prisant LM, Neutel JM, Ferdinand K., et al. Low-dose combination therapy as first-line hypertension treatment for blacks and nonblacks. J Natl Med Assoc. 1999 ; 91: 40-48.
21. Prisant LM, Neutel JM, Papademetriou V., DeQuattro V., hall WD, Weir MR Low-dose combination treatment for hypertension versus single-drug treatment-bisoprolol/ hydrochlorothiazide versus amlodipine, enalapril, and placebo: combined analysis of comparative studies. Am J Ther. 1998 ; 5: 313-321.
22. Prisant LM, Weir MR, Frishman WH, Neutal JM, Davidov ME, Lewin AJ Self-reported sexual dysfunction in men and women treated with bisoprolol, hydrochlorothiazide, enalapril, amlodipine, placebo, or bisoprolol/ hydrochlorothiazide. J Clin Hypertens (Greenwich). 1999 ; 1: 22-26.
23. Burris JF, Mroczek WJ A first-line treatment option for elderly hypertensive patients: a low-dose multimechanism a -blocker/diuretic. Am J Geriatr Cardiol. 1997 ; 6: 40-46.
24. Girerd X., Mosnier M. [Factors predicting blood pressure normalization in hypertensive patients treated with a fixed-dose combination of bisoprolol 2.5 mg/hydrochlorothiazide/6.25 mg]. Arch Mal Coeur Vaiss. 2003 ; 96: 776-779.
25. Benetos A., Adamopoulos C., Argyriadis P., Bean K., Consoli S., Safar M. Clinical results with bisoprolol 2.5 mg/hydrochlorothiazide 6.25 mg combination in systolic hypertension in the elderly. J Hypertens Suppl. 2002 ; 20: S21 - S25.
26. Benetos A., Consoli S., Safavian A., Dubanchet A., Safar M. Efficacy, safety, and effects on quality of life of bisoprolol/hydrochlorothiazide versus amlodipine in elderly patients with systolic hypertension. Am Heart J. 2000 ; 140: 623-629.
27. Unzueta Montoya A., Unzueta A. Jr, Ordonez Toquero G., Villasis Keever MA, Cocoletzi Lopez J., Medina Santillan R. Comparative study between bisoprolol and metoprolol, combined with hydrochlorothiazide, as antihypertensive therapy. Arch Inst Cardiol Mex. 2000 ; 70: 589-595.
28. Sorof JM, Cargo P., Graepel J., et al. Beta-blocker/thiazide combination for treatment of hypertensive children: a randomized double-blind, placebo-controlled trial. Pediatr Nephrol. 2002 ; 17: 345-350.